• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Threshold Pharmaceuticals Inc

+ Add to Watchlist

THLD:US

4.0900 USD 0.0300 0.73%

As of 13:45:51 ET on 07/28/2014.

Snapshot for Threshold Pharmaceuticals Inc (THLD)

Open: 4.1200 Day's Range: 3.9720 - 4.1200 Volume: 239,072
Previous Close: 4.1200 52wk Range: 3.5100 - 5.9300 1-Yr Rtn: -27.35%

Stock Chart for THLD

No chart data available.
  • THLD:US 4.0900
  • 1D
  • 1M
  • 1Y
4.1200
Interactive THLD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THLD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4700
Est. EPS (USD) (12/2014) -0.4970
Est. PEG Ratio -
Market Cap (M USD) 237.84
Shares Outstanding (M) 59.35
30 Day Average Volume 380,150
Price/Book (mrq) -
Price/Sale (ttm) 18.0658
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THLD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THLD

Threshold Pharmaceuticals Inc. is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that targets fundamental differences in metabolism between normal and certain diseased cells.

Harold E Selick "Barry"Chief Executive OfficerTillman PearceChief Medical Officer
Robert L Simon "Bob"Senior VP:Regulatory AffairsJoel A FernandesVP:Finance/Controller
More Company Profile & Key Executives for THLD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil